FDA expands use of Sapien 3 artificial heart valve for high-risk patients

By Newsroom America Feeds at 5 Jun 2017

The U.S. Food and Drug Administration today approved an expanded indication for the Sapien 3 Transcatheter Heart Valve (THV) for patients with symptomatic heart disease due to failure of a previously placed bioprosthetic aortic or mitral valve whose risk of death or severe complications from repeat surgery is high or greater.

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm561924.htm

Categories:
Tags:

[D] [Digg] [FB] [R] [SU] [Tweet] [G]

NEWSMAIL